BR112017017333A2 - uso de cosmético oral de uma combinação de agentes ativos e processo cosmético para aumentar e/ou manter a espessura de fibras de cabelo, e/ou limitar o afinamento destas - Google Patents

uso de cosmético oral de uma combinação de agentes ativos e processo cosmético para aumentar e/ou manter a espessura de fibras de cabelo, e/ou limitar o afinamento destas

Info

Publication number
BR112017017333A2
BR112017017333A2 BR112017017333A BR112017017333A BR112017017333A2 BR 112017017333 A2 BR112017017333 A2 BR 112017017333A2 BR 112017017333 A BR112017017333 A BR 112017017333A BR 112017017333 A BR112017017333 A BR 112017017333A BR 112017017333 A2 BR112017017333 A2 BR 112017017333A2
Authority
BR
Brazil
Prior art keywords
cosmetic
thinning
maintain
thickness
hair fibers
Prior art date
Application number
BR112017017333A
Other languages
English (en)
Inventor
Piccardi Nathalie
Original Assignee
Nutricos Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricos Tech filed Critical Nutricos Tech
Publication of BR112017017333A2 publication Critical patent/BR112017017333A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/002—Preparations for repairing the hair, e.g. hair cure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

a invenção diz respeito ao uso de cosmético oral de uma combinação de agentes ativos compreendendo pelo menos taurina, um derivado desta e/ou sal aceitável desta, pelo menos vitamina b8 ou um derivado desta e pelo menos um extrato de uva, para aumentar e/ou manter a espessura de fibras de cabelo e/ou limitar o afinamento de fibras de cabelo. a invenção também diz respeito a um processo cosmético para esta finalidade.
BR112017017333A 2015-02-13 2016-02-12 uso de cosmético oral de uma combinação de agentes ativos e processo cosmético para aumentar e/ou manter a espessura de fibras de cabelo, e/ou limitar o afinamento destas BR112017017333A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1551201A FR3032612B1 (fr) 2015-02-13 2015-02-13 Utilisation d'une association de taurine ou un de ses derives, de biotine et d'extrait de raisins pour lutter contre les cheveux fins
PCT/EP2016/052960 WO2016128532A1 (en) 2015-02-13 2016-02-12 Use of a combination of taurine or a derivative thereof, biotin and grape extract for combating fine hair

Publications (1)

Publication Number Publication Date
BR112017017333A2 true BR112017017333A2 (pt) 2018-04-03

Family

ID=52829149

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017333A BR112017017333A2 (pt) 2015-02-13 2016-02-12 uso de cosmético oral de uma combinação de agentes ativos e processo cosmético para aumentar e/ou manter a espessura de fibras de cabelo, e/ou limitar o afinamento destas

Country Status (8)

Country Link
US (1) US20180036214A1 (pt)
EP (1) EP3256095B1 (pt)
CN (1) CN107205919A (pt)
BR (1) BR112017017333A2 (pt)
CA (1) CA2975198A1 (pt)
ES (1) ES2949985T3 (pt)
FR (1) FR3032612B1 (pt)
WO (1) WO2016128532A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3235490A1 (en) * 2016-04-18 2017-10-25 L'Oréal Composition for improving hair quality

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002097116A (ja) * 2000-09-19 2002-04-02 Shiseido Co Ltd 細胞賦活剤
AU2003253075B2 (en) * 2002-06-21 2007-07-19 L'oreal Use of taurine or derivatives thereof for the treatment of alopecia
BR0314142A (pt) * 2002-09-09 2005-06-28 Nestec Sa Composição administrável oralmente para melhoria da qualidade do cabelo ou da pele
FR2861594B1 (fr) * 2003-11-03 2006-01-20 Baudry Jacquet Composition contenant un extrait de the vert et de la vitamine c
EP1932509A1 (fr) * 2006-12-14 2008-06-18 L'oreal Utilisation orale d'au moins un acide gras monoinsaturé pour améliorer la chevelure
FR2953722B1 (fr) * 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.

Also Published As

Publication number Publication date
EP3256095A1 (en) 2017-12-20
US20180036214A1 (en) 2018-02-08
EP3256095B1 (en) 2023-06-28
ES2949985T3 (es) 2023-10-04
WO2016128532A1 (en) 2016-08-18
CA2975198A1 (en) 2016-08-18
FR3032612B1 (fr) 2017-02-24
CN107205919A (zh) 2017-09-26
FR3032612A1 (fr) 2016-08-19
EP3256095C0 (en) 2023-06-28

Similar Documents

Publication Publication Date Title
CY1122583T1 (el) Αναστολεις πρωτεασωματος για αντιμετωπιση μιας διαταραχης η οποια σχετιζεται με μια συσσωρευση μη-αποικοδομημενης μη-φυσιολογικης πρωτεϊνης η ενος καρκινου
CL2018000542A1 (es) Nuevos derivados de fenoximetilo.
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
CL2016002812A1 (es) Uso de ácido 3-2,3,5,6-tetrafluoro-3-trifluorometoxi-bifenil-4-ilcarbamoil-tiofeno-2-carboxílico para preparar un medicamento útil para tratar una enfermedad ocular que es uveítis, ojo seco o causada por un adenovirus composición formulación.
BR112019006160A2 (pt) composições e métodos para o tratamento das condições oftálmicas
CL2016001715A1 (es) Nuevos inhibidores de glutaminasa
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
BR112017010720A2 (pt) gel aquoso ou alcoólico aquoso de filossilicatos sintéticos como agente de viscosidade, de efeito matificante e/ou agente homogeneizador de aplicação
BR112019003731A2 (pt) aplicação de pridopidina para tratamento de distonias
BR112018015367A2 (pt) carreadores oromucosais de nanofibra para tratamento terapêutico
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
BR112018070497A2 (pt) métodos e formulações farmacêuticas para tratamento de condições oculares
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
CO2019011265A2 (es) Moduladores de la expresión de pcsk9
BR112018073862A2 (pt) composição para cuidado dos cabelos
BR112018012927A2 (pt) reguladores cftr e métodos de uso dos mesmos
BR112019003816A2 (pt) composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição
BR112018014762A2 (pt) método de tratamento da doença de alzheimer (da) precoce
BR112018012949A2 (pt) reguladores cftr e métodos de uso dos mesmos
BR112019000706A8 (pt) Agente de estímulo do receptor 1b de 5-hidroxitriptamina para reparo de pele e/ou cabelo
BR102020023578A8 (pt) Composições e métodos para tratamento do olho
BR112018012934A2 (pt) reguladores cftr e métodos de uso dos mesmos
BR112017017333A2 (pt) uso de cosmético oral de uma combinação de agentes ativos e processo cosmético para aumentar e/ou manter a espessura de fibras de cabelo, e/ou limitar o afinamento destas
CO2020003134A2 (es) Moduladores de la expresión de enac

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: VIDE E-PARECER

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]